Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Trial Profile

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Meropenem (Primary)
  • Indications Acute enterocolitis; Bacterial infections; Intra-abdominal infections
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms Meropenem PK
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 28 Nov 2011 Primary endoints added as reported by ClinicalTrials.gov.
    • 14 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top